Feasibility Study of Phototherapy System to Treat H Pylori

Status Recruiting

Clinical Trial Summary

This purpose of this study is to determine whether phototherapy can be used to safely and effectively treat H pylori.

Clinical Trial Description

H pylori causes almost all peptic ulcers and many gastric cancers and is widely prevalent worldwide. Treatment by multiple antibiotics and proton pump inhibitors is effective but are compromised today by significant non compliance due to side effects and duration of required treatment. Also, the increase in antibiotic resistance coupled with the decreased availability of new antibiotics project a significant population of patients who will not be treatable with antibiotics.

A special, visible-light based phototherapy system has been demonstrated to significantly decrease the viability of H pylori in vitro and in a brief clinical experiment.

This study will evaluate the safety and short term efficacy in up to 60 patients of the phototherapy system to treat H pylori. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Helicobacter Pylori

Clinical Trial Details

NCT number	NCT00306280
Study type	Interventional
Source	LumeRx
Contact
Status	Recruiting
Phase	N/A
Start date	March 2006
Completion date	March 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02892409` - TAK-438 Bismuth Drug Interaction Study	Phase 1
Completed	`NCT05073367` - A Study Reviewing Medical Records of Adults With Helicobacter Pylori Infections in China
Completed	`NCT00596401` - The Preventive Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer
Not yet recruiting	`NCT04101708` - A Comparison of High-dose Dual Therapy and Half-dose Clarithromycin-containing Bismuth Quadruple Therapy for H.P Eradication in Elderly Patients	Phase 4
Recruiting	`NCT04030715` - The Associations Between the Gastric Mucosal Pathology and the Eradication Rate of H.Pylori :A Multicenter Study	N/A
Recruiting	`NCT04029493` - The Situation of Re-infection of Helicobacter Pylori After Successful Eradication
Recruiting	`NCT04029415` - The Study of the Antimicrobial Resistance of Helicobacter Pylori in Shandong Province
Not yet recruiting	`NCT02933229` - The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study	Phase 4
Not yet recruiting	`NCT02934048` - Optimal Duration of Antimicrobial Susceptibility Test (AST) Guided Rescue Therapy for Helicobacter Pylori Infection	Phase 4
Recruiting	`NCT05184491` - Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management	Phase 4
Recruiting	`NCT05790525` - Effect of Oral Helicobacter Pylori Infection on the Efficacy of Gastroluminal Helicobacter Pylori Eradication Therapy	Phase 4
Completed	`NCT05790512` - Association of Oral Helicobacter Pylori Infection With Gastric Helicobacter Pylori Infection
Recruiting	`NCT05276557` - PyloPlus Urea Breath Test System Pediatric Safety and Efficacy Study	Phase 3
Recruiting	`NCT03177629` - H. Pylori Eradication for Moderate ITP	Phase 3
Recruiting	`NCT05053945` - Helicobacter Pylori, Atrophic Gastritis and Intestinal Metaplasia Registry and Prospective Study
Recruiting	`NCT05449028` - Helicobacter Pylori Eradication Therapy in Portugal	N/A
Active, not recruiting	`NCT02675010` - Value of Additional Corpus Biopsy for Diagnosis of H Pylori in Atrophic Gastritis. Prospective Non-randomized Study	N/A
Withdrawn	`NCT00467155` - Helicobacter in The Gambia (Part 2)	N/A
Completed	`NCT03716622` - A Comparison of Clarithromycin-based and Furazolidone-based Bismuth-containing Regimens for H. Pylori Eradication	Phase 4
Not yet recruiting	`NCT04937426` - Development of a Laboratory Test for the Detection of a Fluorescent-labeled Urease Inhibitor Marker Attached to Helicobacter Pylori	N/A